Maria‐Cruz Ferrer‐Gracia
A5052944202- Cardiac Valve Diseases and Treatments
- Coronary Interventions and Diagnostics
- Infective Endocarditis Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Cardiac Imaging and Diagnostics
- Cardiac pacing and defibrillation studies
- Congenital Heart Disease Studies
- Cerebrovascular and Carotid Artery Diseases
- Frailty in Older Adults
- Cardiovascular Function and Risk Factors
- Cardiac, Anesthesia and Surgical Outcomes
- Aortic Disease and Treatment Approaches
- Cardiac Arrhythmias and Treatments
Hospital Universitario Miguel Servet
2020-2025
Hospital Clínico Universitario Lozano Blesa
2017
ABSTRACT Background Limited data exist on the impact of polyvascular disease (PolyVD) clinical outcomes in female patients undergoing transcatheter aortic valve replacement (TAVR). We therefore sought to investigate women with versus without PolyVD TAVR. Methods Female participants from multicentre Women's International Transcatheter Aortic Valve Implantation (WIN‐TAVI) registry were categorized based presence or absence PolyVD. The population was defined as atherosclerotic affecting ≥ 2...
Transcatheter aortic valve embolization is a serious complication of transcatheter replacement (TAVR). We present the case patient who required implantation three self-expandable valves (SEVs) owing to two them.
Abstract Objective To evaluate the incidence, predictors and outcomes of female patients with patient‐prosthesis mismatch (PPM) following transcatheter aortic valve intervention (TAVI) for severe stenosis (AS). Background Female AS TAVI recipients have a significantly lower mortality than surgical replacement (SAVR) recipients, which could be attributed to potentially PPM rates. has been associated rates compared SAVR. in females post not investigated date. Methods The WIN‐TAVI (Women's...
Abstract Objectives To assess the impact of anemia on clinical outcomes in female patients enrolled Women's InterNational transcatheter aortic valve implantation (WIN‐TAVI) registry. Background Anemia is highly prevalent among females who constitute half TAVI candidates, yet, its significance remains poorly investigated. Methods Patients were divided into three groups according to preprocedural hemoglobin (Hb) level: (1) no (Hb ≥12 g/dl), (2) mild‐to‐moderate (10 ≤ Hb <12 and (3) severe...
To describe the incidence, predictors, and clinical impact of permanent pacemaker insertion (PPI) following transcatheter aortic valve replacement (TAVR) in women.Data on complicating TAVR women are scarce.The Women's International Transcatheter Aortic Valve implantation (WIN-TAVI) is a prospective registry evaluating safety efficacy women. We included patients without preprocedural pacemakers divided them into two groups: (1) PPI (2) no-PPI. identified predictors using logistic regression...
Background: Frailty has been shown to significantly affect outcomes after transcatheter aortic valve replacement (TAVR). The impact of pre-frailty on TAVR in women is still unclear. Aim: To assess the and frailty enrolled Women's InterNational implantation (WIN-TAVI) registry. Materials methods: WIN-TAVI was a multinational, prospective, observational registry, which at intermediate or high preoperative risk undergoing TAVR. Patients included this registry were divided into three groups,...